Histone deacetylase inhibitors and methods of use thereof
US7507828B2 · kind B2 · utility
5Cited by
6References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 11, 2004 |
| Grant date | Mar 24, 2009 |
| Priority date | — |
| Expiry date | May 11, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
One aspect of the invention relates to HDAC inhibitors. Methods of sensitizing a cancer cell to the cytotoxic effects of radiotherapy are also provided. The invention also provides methods for treating cancer and methods for treating neurological diseases. Additionally, the invention further provides pharmaceutical compositions comprising an HDAC inhibitor of the invention, and kits comprising a container containing an HDAC inhibitor of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.